Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rectal Cancer Patients”

3,812 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,812 results

Testing effectiveness (Phase 2)Study completedNCT00091182
What this trial is testing

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Extragonadal Germ Cell TumorChildhood Hepatoblastoma+23 more
National Cancer Institute (NCI) 180
Early research (Phase 1)Study completedNCT00575562
What this trial is testing

Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
Kyowa Kirin, Inc. 42
Not applicableWithdrawnNCT05951842
What this trial is testing

Anesthesia, TIVA, Balanced Anesthesia, NK Cell

Who this might be right for
Colorectal Cancer
Gangnam Severance Hospital
Not applicableUnknownNCT04588805
What this trial is testing

Incidence Rate of Perioperiative VTE in Colorectal Cancer Patients : a Multicenter Prospective Observational Cohort Study

Who this might be right for
Incidence Rate of Perioperiative Venous Thromboembolism(VTE) in Colorectal Cancer Patients
Beijing Friendship Hospital 1,217
Testing effectiveness (Phase 2)UnknownNCT04247256
What this trial is testing

Trial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRI

Who this might be right for
Metastatic Colorectal Cancer
Scandion Oncology A/S 35
Testing effectiveness (Phase 2)Looking for participantsNCT05784688
What this trial is testing

Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorBiliary Tract CancerHead and Neck Squamous Cell Carcinoma+1 more
TiumBio Co., Ltd. 140
Not applicableUnknownNCT04662853
What this trial is testing

Gut Microbiota and Color-rectal Cancer.

Who this might be right for
CancerColo-rectal CancerDiagnoses Disease+2 more
Maimónides Biomedical Research Institute of Córdoba 153
Not applicableWithdrawnNCT04670588
What this trial is testing

Response Assessment by Circulating Tumor DNA in Patients With Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Medical College of Wisconsin
Not applicableLooking for participantsNCT07676461
What this trial is testing

Oral, Fecal and Intratumoral Microbiome Atlas in Colombian Patients With Advanced Solid Tumors Receiving First-Line Immunotherapy

Who this might be right for
Gastric CancerColorectal CancerBreast Cancer+2 more
Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo 150
Testing effectiveness (Phase 2)Study completedNCT00801294
What this trial is testing

A Phase II Trial of Weekly Alternating Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Boehringer Ingelheim 46
Not applicableLooking for participantsNCT07574502
What this trial is testing

Transcutaneous Electrical Acustimulation on Postoperative Bowel Function Recovery in Elderly Patients

Who this might be right for
Colorectal Cancer (CRC)
Sir Run Run Shaw Hospital 190
Not applicableNot Yet RecruitingNCT06729645
What this trial is testing

External Beam Radiotherapy Combined With Endorectal High-dose-rate Brachytherapy in Elderly and Frail Patients With Rectal Cancer

Who this might be right for
Rectal Cancer
University Hospital of Cologne 80
Not applicableUnknownNCT04758195
What this trial is testing

Transanal Irrigation to Prevent Major Low Anterior Resection Syndrome

Who this might be right for
Low Anterior Resection Syndrome
Sixth Affiliated Hospital, Sun Yat-sen University 100
Not applicableStudy completedNCT04670445
What this trial is testing

Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer

Who this might be right for
Stage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more
Massachusetts General Hospital 199
Testing effectiveness (Phase 2)Active Not RecruitingNCT03654131
What this trial is testing

Microwave Ablation Versus Stereotactic Body Radiotherapy for Colorectal Liver Metastases in Oligometastatic Disease: a Prospective, Randomised, Phase 2 Trial

Who this might be right for
Colorectal CarcinomaLiver Metastases
Rigshospitalet, Denmark 100
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Early research (Phase 1)Study completedNCT00603356
What this trial is testing

Phase I Study of OSI-930 and Erlotinib in Cancer Tumors

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Inc 60
Testing effectiveness (Phase 2)UnknownNCT01348256
What this trial is testing

Study With Dendritic Cell Immunotherapy in Resected Hepatic Metastasis of Colorectal Carcinoma

Who this might be right for
Colorectal CarcinomaHepatic Metastasis
Clinica Universidad de Navarra, Universidad de Navarra 58
Early research (Phase 1)UnknownNCT05213195
What this trial is testing

NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer

Who this might be right for
Refractory Metastatic Colorectal Cancer
Zhejiang University 38
Testing effectiveness (Phase 2)Study completedNCT01326000
What this trial is testing

RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 169
Next Page